We are live on ! Find out more
CC

ClearArc Capital Portfolio holdings

AUM $257M
1-Year Est. Return 33.81%
This Fund
S&P 500
This Quarter Est. Return
+0.23%
1 Year Est. Return
+33.81%
3 Year Est. Return
+63.41%
5 Year Est. Return
+95.17%
10 Year Est. Return
AUM
$546M
AUM Growth
+$58.8M
Cap. Flow
+$64.2M
Cap. Flow %
11.75%
Top 10 Hldgs %
16.77%
Holding
463
New
30
Increased
395
Reduced
28
Closed
6

Top Buys

Rank Stock Value
1
RTX icon
RTX Corp
RTX
+$3.46M
2
CLDT
Chatham Lodging
CLDT
+$2.26M
3
CVX icon
Chevron
CVX
+$2.26M
4
AAPL icon
Apple
AAPL
+$2.18M
5
RAI
Reynolds American Inc
RAI
+$1.75M

Sector Composition

Rank Sector Weight
1 Financials 15.27%
2 Healthcare 14.47%
3 Technology 13.69%
4 Industrials 9.6%
5 Consumer Staples 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APC
151
DELISTED
Anadarko Petroleum
APC
$982K 0.18%
12,574
+1,591
+14% +$138K
AMT icon
152
American Tower
AMT
$80.4B
$977K 0.18%
10,474
+1,296
+14% +$123K
TEVA icon
153
Teva Pharmaceuticals
TEVA
$41.2B
$971K 0.18%
16,423
-22
-0.1% -$1.36K
HZNP
154
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$969K 0.18%
27,894
-153
-0.5% -$4.67K
IP icon
155
International Paper
IP
$22B
$967K 0.18%
21,457
+2,422
+13% +$120K
YUM icon
156
Yum! Brands
YUM
$41.1B
$964K 0.18%
14,891
+1,838
+14% +$116K
IVZ icon
157
Invesco
IVZ
$13.9B
$960K 0.18%
25,604
+2,924
+13% +$117K
KMB icon
158
Kimberly-Clark
KMB
$36.5B
$955K 0.17%
9,014
+1,076
+14% +$117K
ADBE icon
159
Adobe
ADBE
$105B
$953K 0.17%
11,766
+1,460
+14% +$114K
REGN icon
160
Regeneron Pharmaceuticals
REGN
$80.8B
$952K 0.17%
1,867
+262
+16% +$128K
RTN
161
DELISTED
Raytheon Company
RTN
$944K 0.17%
9,870
+1,118
+13% +$117K
SO icon
162
Southern Company
SO
$107B
$942K 0.17%
22,480
+2,755
+14% +$120K
VFC icon
163
VF Corp
VFC
$5.89B
$937K 0.17%
14,274
+1,620
+13% +$110K
SCHW
164
Charles Schwab
SCHW
$187B
$934K 0.17%
28,611
+3,595
+14% +$114K
ADP icon
165
Automatic Data Processing
ADP
$108B
$933K 0.17%
11,623
+1,320
+13% +$113K
CTSH icon
166
Cognizant
CTSH
$26B
$923K 0.17%
15,112
+1,885
+14% +$118K
GDX icon
167
VanEck Gold Miners ETF
GDX
$27.4B
$923K 0.17%
51,956
-329
-0.6% -$6.39K
EMR icon
168
Emerson Electric
EMR
$88.3B
$917K 0.17%
16,543
+1,670
+11% +$98.1K
HAL icon
169
Halliburton
HAL
$26.6B
$907K 0.17%
21,060
+2,658
+14% +$122K
BAX icon
170
Baxter International
BAX
$14.2B
$871K 0.16%
22,919
+2,685
+13% +$100K
RDS.B
171
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$866K 0.16%
15,099
+7,050
+88% +$436K
SE
172
DELISTED
Spectra Energy Corp Wi
SE
$866K 0.16%
26,572
+3,093
+13% +$110K
CTAS icon
173
Cintas
CTAS
$81.3B
$858K 0.16%
+40,592
New +$852K
PX
174
DELISTED
Praxair Inc
PX
$853K 0.16%
7,137
+881
+14% +$107K
LII icon
175
Lennox International
LII
$15.2B
$851K 0.16%
+7,906
New +$878K

Similar funds

ClearArc Capital's Q2 2015 Portfolio in Review

As of Q2 2015, ClearArc Capital held 463 positions worth $546M, up 12% from $488M the previous quarter. Its ten largest holdings account for 17% of the portfolio.

ClearArc Capital deployed $64.2M of net new capital in Q2 2015, opening 30 new positions and adding to 395 existing holdings. Its largest new stake was Chatham Lodging: 80,222 shares worth $2.12M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Cardinal Health, an estimated $1.02M trimmed.

  • ClearArc Capital's largest Q2 2015 buy was Chatham Lodging: 80,222 shares worth $2.12M.
  • ClearArc Capital added most to RTX Corp in Q2 2015, an estimated $3.46M increase.
  • ClearArc Capital's biggest Q2 2015 reduction was Cardinal Health, cutting an estimated $1.02M.
  • ClearArc Capital fully exited LORILLARD INC COM STK in Q2 2015, selling an estimated $2.02M.
  • ClearArc Capital's ten largest holdings make up 17% of its $546M portfolio in Q2 2015.
  • ClearArc Capital opened 30 new positions and closed 6 in Q2 2015.
  • ClearArc Capital's portfolio value rose 12% quarter-over-quarter to $546M.

Based on ClearArc Capital's 13F filing for Q2 2015, filed 14 Aug 2015.